Table on assessment times for Concerned Member State cases 2020

Updated 17 March 2021

Table 1. Concerned member state cases

Concerned member state cases Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2019 20 30 -10 101 99 98
2nd quarter 2019 23 30 -7 113 109 96
3rd quarter 2019
 18 30 -12 127 121 95
4th quarter 2019
 42 30 12 39 35 90
1st quarter 2020 19 30 -11 50 49 98
2nd quarter 2020 22 30 -8 75 65 87
3rd quarter 2020 30 30 0 89 60 67
4th quarter 2020 32 30 2 73 57 78

Tabel 2. Concerned member state cases - Human medicines

Concerenced member state cases - HUM Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2019
 20 30 -10 88 86 98
2nd quarter 2019
 24 30 -6 98 94 96
3rd quarter 2019
 17 30 -13 104 99 95
4th quarter 2019
 46 30 16 33 29 88
1st quarter 2020 21 30 -9 35 34 97
2nd quarter 2020 20 30 -10 64 57 89
3rd quarter 2020 30 30 0 77 54 70
4th quarter 2020 30 30 0 61 51 84

Tabel 3. Concerned member state cases - Veterinary medicines

Concerenced member state cases - VET Average assessment time Target days Difference between assessment time and target days No. of cases measured
No. of drug IDs		 No. of cases within 30 days Share of cases within 30 days per cent
1st quarter 2019
 20 30 -10 13 13 100
2nd quarter 2019
 19 30 -11 15 15 100
3rd quarter 2019
 22 30 -8 23 22 96
4th quarter 2019
 21 30 -9 6 6 100
1st quarter 2020 14 30 -16 15 15 100
2nd quarter 2020 33 30 3 11 8 73
3rd quarter 2020 31 30 1 12 6 50
4th quarter 2020 45 30 15 12 6 50